Mellors JW - Search Results

1

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. Henrich TJ, et al. Among authors: mellors jw. PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29112956 Free PMC article.

2

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Mellors JW, et al. Science. 1996 May 24;272(5265):1167-70. doi: 10.1126/science.272.5265.1167. Science. 1996. PMID: 8638160

3

Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.

Rosowsky A, Fu H, Pai N, Mellors J, Richman DD, Hostetler KY. Rosowsky A, et al. J Med Chem. 1997 Aug 1;40(16):2482-90. doi: 10.1021/jm970172f. J Med Chem. 1997. PMID: 9258355

4

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA. Gulick RM, et al. Among authors: mellors jw. N Engl J Med. 1997 Sep 11;337(11):734-9. doi: 10.1056/NEJM199709113371102. N Engl J Med. 1997. PMID: 9287228 Free article. Clinical Trial.

5

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vézinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. Hirsch MS, et al. Among authors: mellors jw. JAMA. 1998 Jun 24;279(24):1984-91. doi: 10.1001/jama.279.24.1984. JAMA. 1998. PMID: 9643863 Review.

6

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Jonas L, Meibohm A, Holder D, Schleif WA, Condra JH, Emini EA, Isaacs R, Chodakewitz JA, Richman DD. Gulick RM, et al. Among authors: mellors jw. JAMA. 1998 Jul 1;280(1):35-41. doi: 10.1001/jama.280.1.35. JAMA. 1998. PMID: 9660361 Clinical Trial.

7

A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.

Hirsch M, Steigbigel R, Staszewski S, Mellors J, Scerpella E, Hirschel B, Lange J, Squires K, Rawlins S, Meibohm A, Leavitt R. Hirsch M, et al. J Infect Dis. 1999 Sep;180(3):659-65. doi: 10.1086/314948. J Infect Dis. 1999. PMID: 10438352 Clinical Trial.

8

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Hirsch MS, Brun-Vézinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, Richman DD. Hirsch MS, et al. Among authors: mellors jw. JAMA. 2000 May 10;283(18):2417-26. doi: 10.1001/jama.283.18.2417. JAMA. 2000. PMID: 10815085

9

In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.

Hostetler KY, Hammond JL, Kini GD, Hostetler SE, Beadle JR, Aldern KA, Chou TC, Richman DD, Mellors JW. Hostetler KY, et al. Among authors: mellors jw. Antivir Chem Chemother. 2000 May;11(3):213-9. doi: 10.1177/095632020001100304. Antivir Chem Chemother. 2000. PMID: 10901292 Free article.

10

Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells.

Fan Z, Huang XL, Borowski L, Mellors JW, Rinaldo CR Jr. Fan Z, et al. Among authors: mellors jw. J Virol. 2001 May;75(9):4413-9. doi: 10.1128/JVI.75.9.4413-4419.2001. J Virol. 2001. PMID: 11287592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters